Schedule Dispatches

Schedule dispatches give a summary of changes coming out in the next month.

This is an early notification of the changes to be announced in the Update to the Pharmaceutical Schedule.

The full Update is available as a PDF(external link)

The changes will be published in the online Schedule around the 23rd of this month and are effective from next month.

For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz

April 2026

New Listings

  • Amoxicillin (Amoxycillin Sandoz) cap 500 mg – up to 30 cap available on a PSO and up to 10 x the maximum PSO quantity for RFPP (p’code 2712601)
  • Bortezomib (Bortezomib Eugia) inj 3.5 mg vial – PCT only – Specialist – Special Authority (p’code 2723832)
  • Candesartan cilexetil (Candesartan Viatris Sante) tab 4 mg (p’code 2725355), tab 8 mg (2725363), tab 16 mg (p’code 2725371) and tab 32 mg (p’code 2725398)
  • Cyclophosphamide (Cyclophosphamide Seacross) inj 2 g vial – PCT only – Specialist (p’code 2725614)
  • Dexamfetamine sulfate (Dexamfetamine Aspen) tab 5 mg – Special Authority – Retail pharmacy – only on a controlled drug form and safety medicine; prescriber may determine dispensing frequency (p’code 2642298)
  • Elexacaftor with tezacaftor, ivacaftor and ivacaftor (Trikafta) – PCT only – Special Authority
  • Oral granules elexacaftor 80 mg with tezacaftor 40 mg, ivacaftor 60 mg (28) and ivacaftor 59.5mg (28), sachets, 56 OP (p’code 2726246)
  • Oral granules elexacaftor 100 mg with tezacaftor 50 mg, ivacaftor 75 mg (28) and ivacaftor 75 mg (28), sachets, 56 OP (p’code 2726238)
  • Ezetimibe with simvastatin (Zimybe) tab 10 mg with simvastatin 80 mg (p’code 2725622)
  • Fluconazole (Flucazole) cap 150 mg (p’code 2173824)
  • Ipratropium bromide (Ipratropium Viatris) nebuliser soln, 250 mcg per ml, 2 ml ampoule – Up to 40 neb available on a PSO, s29 and wastage claimable (p’code 2724863)
  • Ivacaftor (Kalydeco) oral granules 13.4 mg sachet (p’code 2726254) and oral granules 25 mg sachet (p’code 2726262) – PCT only – Specialist – Special Authority
  • Lansoprazole (Lanzol Relief) cap 15 mg (p’code 2726017)
  • Naproxen (Noflam 250) tab 250 mg (p’code 2725495)
  • Oral feed (powder) (Ensure) powder (chocolate (p’code 2720256)) and (vanilla (p’code 2720248)), 800 g OP – Special Authority – Hospital pharmacy [HP3]
  • Pegfilgrastim (Ziextenzo) inj 6 mg per 0.6 ml syringe – Special Authority – Retail pharmacy (p’code 2724251)
  • Rosuvastatin (Rosuvastatin - Sandoz) tab 10 mg (p’code 2716720) and tab 40 mg (p’code 2716747) – Special Authority – Retail pharmacy
  • Valaciclovir (Valaciclovir Mylan (p’code 2725991) and Valaciclovir Viatris (p’code 2726009) tab 1,000 mg – S29 and wastage claimable
  • Vanzacaftor with tezacaftor and deutivacaftor (Alyftrek) – PCT only – Special Authority
  • Tab vanzacaftor 4 mg with tezacaftor 20 mg and deutivacaftor 50 mg, 84 OP (p’code 2726203)
  • Tab vanzacaftor 10 mg with tezacaftor 50 mg and deutivacaftor 125 mg, 56 OP (p’code 2726211)
  • Zidovudine with lamivudine (Lamivudine/Zidovudine Viatris) tab 300 mg with lamivudine 150 mg – Special Authority – Retail pharmacy (p’code 2724952)

Changes to restrictions, chemical names and presentations

  • Atezolizumab inj 60 mg per ml, 20 ml vial (Tecentriq) and inj 1 mg for ECP (Baxter) – amended Special Authority criteria
  • Brentuximab vedotin (Adcetris) inj 50 mg vial – amended Special Authority criteria
  • Elexacaftor with tezacaftor, ivacaftor and ivacaftor (Trikafta) – amended Special Authority criteria
  • Tab elexacaftor 50 mg with tezacaftor 25 mg, ivacaftor 37.5 mg (56) and ivacaftor 75 mg (28), 84 OP
  • Tab elexacaftor 100 mg with tezacaftor 50 mg, ivacaftor 75 mg (56) and ivacaftor 150 mg (28), 84 OP
  • Oral granules elexacaftor 80 mg with tezacaftor 40 mg, ivacaftor 60 mg (28) and ivacaftor 59.5mg (28), sachets, 56 OP
  • Oral granules elexacaftor 100 mg with tezacaftor 50 mg, ivacaftor 75 mg (28) and ivacaftor 75 mg (28), sachets, 56 OP
  • Ivacaftor (Kalydeco) tab 150 mg and oral granules 13.4 mg, 25 mg, 50 mg and 75 mg, sachet – amended Special Authority criteria
  • Pembrolizumab inj 25 mg per ml, 4 ml vial (Keytruda) and inj 1 mg for ECP (Baxter) – amended Special Authority criteria

Decreased subsidy

Chemical

Presentation

Fully subsidised brands

Methadone hydrochloride

Tab 5 mg

Methadone BNM

 

Find older dispatches